Liothyronine Sodium Tablets recall: Impurity Out of Spec
Liothyronine Sodium Tablets, USP, 25 mcg, 100-count bottles, Rx only, Distributed by: Sun Pharmaceutical Industries, Inc.Cranbury, NJ 08512, Manufactured by: Sun Pharmaceutical Industries Ltd. Survey No. 259/15, Dadra-396 191,(U.T. of D & NH), India. NDC 62756-590-88
Why was Liothyronine Sodium Tablets recalled?
Failed Impurities/Degradation Specifications.
What should I do if I have this product?
Review the official FDA enforcement record for current instructions.
What to do with a recalled product: refunds, receipts, safe disposal and how to report a problem.
Is my product affected?
Compare the item in your hand with every identifier below from the official FDA record. Only products that match the listed product and lot, UPC or model codes are part of this recall.
Which lot codes, UPCs or models are affected?
Lot #: DNC2204A, Exp. Date 11/2023
- Product
- Liothyronine Sodium Tablets, USP, 25 mcg, 100-count bottles, Rx only, Distributed by: Sun Pharmaceutical Industries, Inc.Cranbury, NJ 08512, Manufactured by: Sun Pharmaceutical Industries Ltd. Survey No. 259/15, Dadra-396 191,(U.T. of D & NH), India. NDC 62756-590-88
- Recalling firm
- SUN PHARMACEUTICAL INDUSTRIES INC
- Quantity
- 2304 Bottles
- Distribution
- Nationwide within the United States
- Recall date
- November 8, 2023
- Classification
- Class II
- Status
- Terminated
- Agency
- FDA (drug)